Evidence map›Paper›PMID 39976674›Full record

ReviewStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2025

Radiation-induced heart disease in breast cancer patients: a narrative review of epidemiology, risk factors, radiotherapy parameters, and prevention.

Aline Van der Vorst, Maarten Lambrecht, Lucas Van Aelst, Jelle Verhoeven, Johanna Jacobs, Adinda Baten, Caroline Weltens

Abstract readReview
PubMed Publisher
In one paragraph

Review in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aline Van der VorstLaboratory of Experimental Radiotherapy, UZ Leuven, Leuven, Belgium. aline.vandervorst@uzleuven.be.ORCID 0009-0006-4983-5609
Maarten LambrechtLaboratory of Experimental Radiotherapy, UZ Leuven, Leuven, Belgium.ORCID 0000-0002-8746-2691
Lucas Van AelstLaboratory of Clinical Cardiology, UZ Leuven, Leuven, Belgium.ORCID 0000-0001-7252-5162
Jelle VerhoevenDepartment of Radiation-Oncology, UZ Leuven, Leuven, Belgium.ORCID 0000-0003-1534-3340
Johanna JacobsLaboratory of Clinical Cardiology, UZ Leuven, Leuven, Belgium.ORCID 0000-0003-2913-6297
Adinda BatenDepartment of Radiation-Oncology, UZ Leuven, Leuven, Belgium.ORCID 0000-0001-7104-7808
Caroline WeltensLaboratory of Experimental Radiotherapy, UZ Leuven, Leuven, Belgium.ORCID 0000-0001-7790-7151

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is the most prevalent cancer in women worldwide; nevertheless, the prognosis is good, with a 5-year overall survival of 80-90%. Therefore, it becomes crucial to strive for high quality of life after cure by minimizing treatment-related toxicity. One such concern is radiation-induced heart disease, which remains a significant focus of ongoing investigations. PURPOSE: The aim of this review is to summarize current knowledge on radiation-induced heart disease in breast cancer patients by giving an overview of its epidemiology, risk factors, radiation parameters related to its development, solutions in radiation practice, and prevention. The goal is to raise awareness and maximize prevention of radiation-induced heart disease.

methodsThe PubMed database was screened for articles published between January 2013 and November 2023 related to the keywords <breast cancer>, <radiotherapy>, <cardiac toxicity>, and <heart-sparing techniques>. Moreover, by screening the literature lists of these publications, additional articles were added.

resultsNinety-four relevant papers remained for final review.

conclusionRadiation-induced heart disease is a rare complication after breast cancer radiotherapy and represents a clinical spectrum of various cardiovascular conditions. Several heart-sparing techniques have been developed, and more attention has been paid to early diagnosis and prevention of radiation-induced heart disease. However, further research remains important to refine radiotherapy techniques and deepen our understanding for improved prevention and treatment of this condition in the future. This clinical review summarizes the existing evidence and literature on radiation-induced heart disease following modern breast cancer radiotherapy, offering clinical guidance for physicians.

Indexed as

Breast NeoplasmsHeart DiseasesRadiation InjuriesFemaleHeartHumansRisk FactorsBreast cancerCardiac toxicityHeart-sparing techniquesRadiotherapy

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.